Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 3.02, 7.01, 9.01 · 8-K

Aeternum Resources Inc.

Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure

Item 1.01 Entry into a Material Definitive Agreement. On September 21, 2026, the registrant, Aeternum Health, Inc. (“Aeternum” or the “Company”), in connection with its entry to the mining and production of critical minerals, acquired from American Renaissance Resources LLC, (“ARR”) under the terms of a Membership Interest Purchase Agreement dated September 21, 2026 (the “Agreement”), all the memb…

Filed Sep 25, 2026Accepted Sep 25, 2026, 9:20 AM EDTCIK 764630Accession 0001493152-26-044256
Share

Company context

Current securities

Historical securities (6)

Recent company filings

  1. 10-Q filingNov 16, 2026
  2. DEF 14C filingSep 1, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 1, 2026
  4. PRE 14C filingAug 21, 2026
  5. 10-Q filingAug 19, 2026

Registered securities in this filing

AETERNUM HEALTH, INC. · 8-K · Filed 2026-09-25

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $.01

Symbol
AETN
Exchange
Not supplied
Classification
COMMON
Filing context

Context: AsOf2026-09-21

Dimensions: Not supplied

Accession 000149315226044256 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 3.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement. On September 21, 2026, the registrant, Aeternum Health, Inc. (“Aeternum” or the “Company”), in connection with its entry to the mining and production of critical minerals, acquired from American Renaissance Resources LLC, (“ARR”) under the terms of a Membership Interest Purchase Agreement dated September 21, 2026 (the “Agreement”), all the membership interests that American Renaissance Resources LLC owned in American Renaissance Minerals LLC (“ARM”) for which the Company has agreed to issue up to 133,333,333 pre-split shares of its common stock or, if required by the terms of a beneficial ownership limitation contained in the Agreement, pre-funded warrants to purchase shares of common stock of the Company, in stages against project milestones. ARM has the right to acquire the Nkamouna Nickel-Cobalt mining project in Cameroon. The Agreement also includes an exhibit for the Investor Rights Agreement between the Company and ARR under which the Company grants observer right to ARR to participate in the Company’s Board meetings with standard rights of exclusion, such as being able to exclude ARR for purposes of protecting the attorney-client privilege, and to register for sale of ARR’s “ Registrable Securities” defined collectively as the Closing Shares, the Contingent Shares and the Common Stock (as those capitalized terms are defined in the Investor Rights Agreement) issuable on exercise of the Pre-Funded Warrants that are held by or potentially issuable to ARR. ARR only receives the observer rights and registration rights if it holds over 9.9% of the Company’s Registrable Securities that it acknowledges it currently does not own, and should it in the future hold over 9.9% of Registrable Securities, the observer rights terminate on the earliest to occur of (i) the date that is fifteen (15) months after the date of the Investor Rights Agreement where the ARR Ownership Percentage is not then greater than 9.9%, or (ii) the first day thereafter when the ARR Ownership Percentage ceases to exceed 9.9% and, with respect to the registration rights, upon the earliest to occur of (i) the first day on which ARR ceases to hold any Registrable Securities or Pre-Funded Warrants, or (ii) the first day on which all of the Registrable Securities held by ARR and issuable upon exercise of Pre-Funded Warrants held by ARR may be resold pursuant to Rule 144 without any volume limitations. The foregoing descriptions of the Agreement and the Investor Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of both agreements that are attached as Exhibit 10.1 and 10.2, respectively, hereto and incorporated herein by reference. Item 3.02. Unregistered Sales of Equity Securities. The matters described in Item 1.01 of this Current Report on Form 8-K are incorporated herein by reference.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosures. On September 25, 2026, the Company issued a press release regarding the purchase of the membership interests of ARM described in Item 1.01 of this Current Report on Form 8-K. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of this Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by Laser Photonics that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm

Exhibit 99.1 Aeternum Resources Announces Agreement to Acquire 100% of American Renaissance Minerals, Sponsor of the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon American Renaissance Minerals, a company focused on advancing the Nkamouna Cobalt-Nickel-Manganese Project in Cameroon, is working with the Government of Cameroon toward the award of a new mining permit over the project, free of prior encumbrance. The transaction consolidates into a single company the joint venture announced on August 7, 2026, under which Aeternum Resources held an option over a 51% interest in American Renaissance Minerals. On closing, Aeternum Resources will own the whole of American Renaissance Minerals and the underlying option arrangements will be terminated. ───────────────────────────────────────────────────────────────────────────────────────────────── Nickel and cobalt are both designated critical minerals by the United States, which imports approximately three quarters of the cobalt it consumes and, excluding recycled material, is almost wholly reliant on imports for its nickel supply. ────────────────────────────────────────────────────────────────────────…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.